Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 inflammation.

VTVT stock outlook: underfollowed T1D catalyst with Phase 3 CATT1 cadisegliatin data due 2H2026, improved timeline and runway ...

The decision comes amid declining demand for the company’s HPV vaccine Gardasil and only a year after the $1 billion site was announced.

The last few decades have revealed that rhinovirus infections are behind a staggering number of asthma attacks, and for people with chronic obstructive pulmonary disease (COPD), they are a leading ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. | Generate:Biomedicines is the latest biotech to benefit from a ...

In winter, particle pollution — also known as particulate matter pollution, or PM2.5 — in the Balkans is the highest in Europe, according to the study's co-authors. The Guardian summarized their ...

A coalition of groups filed a lawsuit against the EPA to challenge the rescindment of a 2009 federal declaration known as the ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest new stock offering in nearly three years.

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Robert F. Kennedy Jr. is waging a multifront war on vaccines, and confidence in them is waning. His main victims, of course, are kids — more than 3,000 measles cases have been reported since he took ...